195 related articles for article (PubMed ID: 29554466)
1. Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling.
Mandelblatt JS; Near AM; Miglioretti DL; Munoz D; Sprague BL; Trentham-Dietz A; Gangnon R; Kurian AW; Weedon-Fekjaer H; Cronin KA; Plevritis SK
Med Decis Making; 2018 Apr; 38(1_suppl):9S-23S. PubMed ID: 29554466
[TBL] [Abstract][Full Text] [Related]
2. Comparing CISNET Breast Cancer Models Using the Maximum Clinical Incidence Reduction Methodology.
van den Broek JJ; van Ravesteyn NT; Mandelblatt JS; Cevik M; Schechter CB; Lee SJ; Huang H; Li Y; Munoz DF; Plevritis SK; de Koning HJ; Stout NK; van Ballegooijen M
Med Decis Making; 2018 Apr; 38(1_suppl):112S-125S. PubMed ID: 29554471
[TBL] [Abstract][Full Text] [Related]
3. Comparing CISNET Breast Cancer Incidence and Mortality Predictions to Observed Clinical Trial Results of Mammography Screening from Ages 40 to 49.
van den Broek JJ; van Ravesteyn NT; Mandelblatt JS; Huang H; Ergun MA; Burnside ES; Xu C; Li Y; Alagoz O; Lee SJ; Stout NK; Song J; Trentham-Dietz A; Plevritis SK; Moss SM; de Koning HJ
Med Decis Making; 2018 Apr; 38(1_suppl):140S-150S. PubMed ID: 29554468
[TBL] [Abstract][Full Text] [Related]
4. A Molecular Subtype-Specific Stochastic Simulation Model of US Breast Cancer Incidence, Survival, and Mortality Trends from 1975 to 2010.
Munoz DF; Xu C; Plevritis SK
Med Decis Making; 2018 Apr; 38(1_suppl):89S-98S. PubMed ID: 29554473
[TBL] [Abstract][Full Text] [Related]
5. Introduction to the Cancer Intervention and Surveillance Modeling Network (CISNET) Breast Cancer Models.
Alagoz O; Berry DA; de Koning HJ; Feuer EJ; Lee SJ; Plevritis SK; Schechter CB; Stout NK; Trentham-Dietz A; Mandelblatt JS;
Med Decis Making; 2018 Apr; 38(1_suppl):3S-8S. PubMed ID: 29554472
[TBL] [Abstract][Full Text] [Related]
6. The Dana-Farber CISNET Model for Breast Cancer Screening Strategies: An Update.
Lee SJ; Li X; Huang H; Zelen M
Med Decis Making; 2018 Apr; 38(1_suppl):44S-53S. PubMed ID: 29554465
[TBL] [Abstract][Full Text] [Related]
7. Estimating Breast Cancer Survival by Molecular Subtype in the Absence of Screening and Adjuvant Treatment.
Munoz DF; Plevritis SK
Med Decis Making; 2018 Apr; 38(1_suppl):32S-43S. PubMed ID: 29554464
[TBL] [Abstract][Full Text] [Related]
8. Modeling Ductal Carcinoma In Situ (DCIS): An Overview of CISNET Model Approaches.
van Ravesteyn NT; van den Broek JJ; Li X; Weedon-Fekjær H; Schechter CB; Alagoz O; Huang X; Weaver DL; Burnside ES; Punglia RS; de Koning HJ; Lee SJ
Med Decis Making; 2018 Apr; 38(1_suppl):126S-139S. PubMed ID: 29554463
[TBL] [Abstract][Full Text] [Related]
9. Structure, Function, and Applications of the Georgetown-Einstein (GE) Breast Cancer Simulation Model.
Schechter CB; Near AM; Jayasekera J; Chandler Y; Mandelblatt JS
Med Decis Making; 2018 Apr; 38(1_suppl):66S-77S. PubMed ID: 29554462
[TBL] [Abstract][Full Text] [Related]
10. Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012.
Plevritis SK; Munoz D; Kurian AW; Stout NK; Alagoz O; Near AM; Lee SJ; van den Broek JJ; Huang X; Schechter CB; Sprague BL; Song J; de Koning HJ; Trentham-Dietz A; van Ravesteyn NT; Gangnon R; Chandler Y; Li Y; Xu C; Ergun MA; Huang H; Berry DA; Mandelblatt JS
JAMA; 2018 Jan; 319(2):154-164. PubMed ID: 29318276
[TBL] [Abstract][Full Text] [Related]
11. A Bayesian Simulation Model for Breast Cancer Screening, Incidence, Treatment, and Mortality.
Huang X; Li Y; Song J; Berry DA
Med Decis Making; 2018 Apr; 38(1_suppl):78S-88S. PubMed ID: 28627297
[TBL] [Abstract][Full Text] [Related]
12. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
13. The University of Wisconsin Breast Cancer Epidemiology Simulation Model: An Update.
Alagoz O; Ergun MA; Cevik M; Sprague BL; Fryback DG; Gangnon RE; Hampton JM; Stout NK; Trentham-Dietz A
Med Decis Making; 2018 Apr; 38(1_suppl):99S-111S. PubMed ID: 29554470
[TBL] [Abstract][Full Text] [Related]
14. Implications of CISNET modeling on number needed to screen and mortality reduction with digital mammography in women 40-49 years old.
Hendrick RE; Helvie MA; Hardesty LA
AJR Am J Roentgenol; 2014 Dec; 203(6):1379-81. PubMed ID: 25415718
[TBL] [Abstract][Full Text] [Related]
15. A stochastic simulation model of U.S. breast cancer mortality trends from 1975 to 2000.
Plevritis SK; Sigal BM; Salzman P; Rosenberg J; Glynn P
J Natl Cancer Inst Monogr; 2006; (36):86-95. PubMed ID: 17032898
[TBL] [Abstract][Full Text] [Related]
16. Reflecting on 20 years of breast cancer modeling in CISNET: Recommendations for future cancer systems modeling efforts.
Trentham-Dietz A; Alagoz O; Chapman C; Huang X; Jayasekera J; van Ravesteyn NT; Lee SJ; Schechter CB; Yeh JM; Plevritis SK; Mandelblatt JS;
PLoS Comput Biol; 2021 Jun; 17(6):e1009020. PubMed ID: 34138842
[TBL] [Abstract][Full Text] [Related]
17. Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality.
Chang Y; Schechter CB; van Ravesteyn NT; Near AM; Heijnsdijk EA; Adams-Campbell L; Levy D; de Koning HJ; Mandelblatt JS
Breast Cancer Res Treat; 2012 Dec; 136(3):823-35. PubMed ID: 23104221
[TBL] [Abstract][Full Text] [Related]
18. Additional common inputs for analyzing impact of adjuvant therapy and mammography on U.S. mortality.
Cronin KA; Mariotto AB; Clarke LD; Feuer EJ
J Natl Cancer Inst Monogr; 2006; (36):26-9. PubMed ID: 17032891
[TBL] [Abstract][Full Text] [Related]
19. Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality.
Munoz D; Near AM; van Ravesteyn NT; Lee SJ; Schechter CB; Alagoz O; Berry DA; Burnside ES; Chang Y; Chisholm G; de Koning HJ; Ali Ergun M; Heijnsdijk EA; Huang H; Stout NK; Sprague BL; Trentham-Dietz A; Mandelblatt JS; Plevritis SK
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25255803
[TBL] [Abstract][Full Text] [Related]
20. Mammography screening: a new estimate of number needed to screen to prevent one breast cancer death.
Hendrick RE; Helvie MA
AJR Am J Roentgenol; 2012 Mar; 198(3):723-8. PubMed ID: 22358016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]